336 related articles for article (PubMed ID: 31662356)
21. High-cost users of Ontario's healthcare services.
Rais S; Nazerian A; Ardal S; Chechulin Y; Bains N; Malikov K
Healthc Policy; 2013 Aug; 9(1):44-51. PubMed ID: 23968673
[TBL] [Abstract][Full Text] [Related]
22. Direct cost associated with acquired brain injury in Ontario.
Chen A; Bushmeneva K; Zagorski B; Colantonio A; Parsons D; Wodchis WP
BMC Neurol; 2012 Aug; 12():76. PubMed ID: 22901094
[TBL] [Abstract][Full Text] [Related]
23. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
Joynt KE; Gawande AA; Orav EJ; Jha AK
JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
[TBL] [Abstract][Full Text] [Related]
24. Estimating direct healthcare costs attributable to laboratory-confirmed Lyme disease in Ontario, Canada: A population-based matched cohort study using health administrative data.
Shing E; Wang J; Khoo E; Evans GA; Moore S; Nelder MP; Patel SN; Russell C; Sider D; Sander B
Zoonoses Public Health; 2019 Jun; 66(4):428-435. PubMed ID: 30665259
[TBL] [Abstract][Full Text] [Related]
25. Incremental Health Care Expenditure of Chronic Cutaneous Ulcers in the United States.
Tripathi R; Knusel KD; Ezaldein HH; Honaker JS; Bordeaux JS; Scott JF
JAMA Dermatol; 2019 Jun; 155(6):694-699. PubMed ID: 30892572
[TBL] [Abstract][Full Text] [Related]
26. [Healthcare expenditure].
Huguier M
Bull Acad Natl Med; 2012 Oct; 196(7):1443-9. PubMed ID: 23815025
[TBL] [Abstract][Full Text] [Related]
27. High health care costs among adults with intellectual and developmental disabilities: a population-based study.
Lunsky Y; De Oliveira C; Wilton A; Wodchis W
J Intellect Disabil Res; 2019 Feb; 63(2):124-137. PubMed ID: 30381849
[TBL] [Abstract][Full Text] [Related]
28. Identifying factors associated with high use of acute care in Canada: protocol of a population-based retrospective cohort study.
Zhang M; Ma J; Xie F; Thabane L
BMJ Open; 2020 Oct; 10(10):e038008. PubMed ID: 33060083
[TBL] [Abstract][Full Text] [Related]
29. Smoking-Attributable Direct Healthcare Expenditure in Lithuania: A Prevalence-Based Annual Cost Approach.
Liutkutė V; Štelemėkas M; Veryga A
Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344246
[No Abstract] [Full Text] [Related]
30. Identifying factors associated with high use of acute care in Canada: a population-based retrospective study.
Zhang M; Ma J; Xie F; Thabane L
Eur J Health Econ; 2023 Dec; 24(9):1505-1515. PubMed ID: 36595151
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and preventable acute care spending among a high cost inpatient population.
Ronksley PE; Kobewka DM; McKay JA; Rothwell DM; Mulpuru S; Forster AJ
BMC Health Serv Res; 2016 May; 16():165. PubMed ID: 27143000
[TBL] [Abstract][Full Text] [Related]
32. Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada.
Tarride JÉ; Adachi JD; Brown JP; Schemitsch E; Slatkovska L; Burke N
Osteoporos Int; 2021 Sep; 32(9):1753-1761. PubMed ID: 33599789
[TBL] [Abstract][Full Text] [Related]
33. High-cost users: drivers of inpatient healthcare expenditure concentration in urban China.
Fan Q; Wang J; Nicholas S; Maitland E
BMC Health Serv Res; 2022 Nov; 22(1):1348. PubMed ID: 36376840
[TBL] [Abstract][Full Text] [Related]
34. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
35. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
36. Healthcare utilization costs of emerging adults with mood and anxiety disorders in an early intervention treatment program compared to a matched cohort.
John-Baptiste AA; Li L; Isaranuwatchai W; Osuch E; Anderson KK
Early Interv Psychiatry; 2019 Dec; 13(6):1439-1446. PubMed ID: 30688032
[TBL] [Abstract][Full Text] [Related]
37. High-Cost Users of Prescription Drugs: National Health Insurance Data from South Korea.
Park D; Lee H; Kim DS
J Gen Intern Med; 2022 Aug; 37(10):2390-2397. PubMed ID: 34704207
[TBL] [Abstract][Full Text] [Related]
38. Identifying Transitional High Cost Users from Unstructured Patient Profiles Written by Primary Care Physicians.
Zhang H; Candido E; Wilton AS; Duchen R; Jaakkimainen L; Wodchis W; Morris Q
Pac Symp Biocomput; 2020; 25():127-138. PubMed ID: 31797592
[TBL] [Abstract][Full Text] [Related]
39. Impact of smoking on health system costs among cancer patients in a retrospective cohort study in Ontario, Canada.
Isaranuwatchai W; de Oliveira C; Mittmann N; Evans WKB; Peter A; Truscott R; Chan KK
BMJ Open; 2019 Jun; 9(6):e026022. PubMed ID: 31230002
[TBL] [Abstract][Full Text] [Related]
40. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.
Gordon SC; Pockros PJ; Terrault NA; Hoop RS; Buikema A; Nerenz D; Hamzeh FM
Hepatology; 2012 Nov; 56(5):1651-60. PubMed ID: 22610658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
